These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 5923911)

  • 61. [Acute peptic ulcer in the course of burns].
    Nasilowski W; Czechowska Z
    Pol Tyg Lek; 1966 Nov; 21(45):1726. PubMed ID: 5982169
    [No Abstract]   [Full Text] [Related]  

  • 62. [Nature of complications in patients with pemphigus in long-term treatment with corticosteroid hormones].
    Khudoleeva AB
    Sov Med; 1974 Mar; 37(3):133-5. PubMed ID: 4846970
    [No Abstract]   [Full Text] [Related]  

  • 63. [Side effects of long term steroid treatment of asthmatic children].
    Menger W
    Respiration; 1970; 27():Suppl:260-9. PubMed ID: 5511277
    [No Abstract]   [Full Text] [Related]  

  • 64. [Therapeutic effects of flucort solution in skin diseases].
    Watanabe S; Yamada M; Aoshima T
    Acta Dermatol Kyoto Engl Ed; 1968 May; 63(2):195-9. PubMed ID: 5755360
    [No Abstract]   [Full Text] [Related]  

  • 65. [Clinical and experimental studies on maximal tubular reabsorptive capacity for glucose and mean threshold in various diseases with glycosuria. 2. Clinical studies].
    Inoue M
    Naika Hokan; 1966; 13(8):413-21. PubMed ID: 6006389
    [No Abstract]   [Full Text] [Related]  

  • 66. [Surgical complications in corticosteroid therapy].
    Fishchenko AIa; Barilo SI; Ryzhanovskaia VM
    Khirurgiia (Mosk); 1980 Nov; (11):96-100. PubMed ID: 7442033
    [No Abstract]   [Full Text] [Related]  

  • 67. Corticosteroid induced osteoporosis.
    Sambrook PN
    J Rheumatol Suppl; 1996 Aug; 45():19-22. PubMed ID: 8856647
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Combined use of vitamin K1 and adrenal cortex hormones in skin diseases].
    Sotomatsu M; Ikada J; Yoshida K; Igarashi H
    Hifuka Kiyo; 1965 Aug; 60(3):267-73. PubMed ID: 5894589
    [No Abstract]   [Full Text] [Related]  

  • 69. Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital.
    Smith MD; Cheah SP; Taylor K; Ahern MJ
    J Rheumatol; 2001 Mar; 28(3):566-70. PubMed ID: 11296960
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [The most common drugs considered harmful to the stomach, Clinical and endoscopic studies].
    Visconti G; Spotti D; Piperno A; Marini U
    Recenti Prog Med; 1980 Jan; 68(1):34-65. PubMed ID: 6988904
    [No Abstract]   [Full Text] [Related]  

  • 71. [Adverse effects of cortisone therapy based on experiences of 264 cases].
    Lenoch F; Dostál C; Vonková A
    Wien Med Wochenschr; 1968 Dec; 118(51):1099-102. PubMed ID: 5729114
    [No Abstract]   [Full Text] [Related]  

  • 72. [Effects and adverse effects of glucocorticoids].
    Scriba PC; von Werder K
    Internist (Berl); 1972 Jul; 13(7):261-9. PubMed ID: 4559266
    [No Abstract]   [Full Text] [Related]  

  • 73. Adverse effects of corticosteroid therapy in neuromuscular diseased patients are common and receive insufficient prophylaxis.
    McDougall D; Bhibhatbhan A; Toth C
    Acta Neurol Scand; 2009 Nov; 120(5):364-7. PubMed ID: 19832774
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Experience in the use of ultralan in dermatologic practice].
    Sharapova GIa; Somov BA; Markin IIa; Borisenko KK
    Vestn Dermatol Venerol; 1970 Apr; 44(4):77-8. PubMed ID: 5459414
    [No Abstract]   [Full Text] [Related]  

  • 75. [Elocom is the newest corticosteroid for local use].
    Tarasenko GN; Patronov IV; Kuz'mina IuV; Tarasenko IuG
    Voen Med Zh; 2004 Jun; 325(6):17-9. PubMed ID: 15327135
    [No Abstract]   [Full Text] [Related]  

  • 76. Misuse of topical corticosteroids: a clinical study in an Iraqi hospital.
    Al-Dhalimi MA; Aljawahiry N
    East Mediterr Health J; 2006 Nov; 12(6):847-52. PubMed ID: 17333832
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Measures for osteoporosis in the dermatological field--vitamin D3 and bisphosphonate].
    Okada N
    Clin Calcium; 2004 Oct; 14(10):145-9. PubMed ID: 15577149
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Topical corticosteroid therapy. Considerations for prescribing and use.
    Nicol NH; Baumeister LL
    Lippincotts Prim Care Pract; 1997; 1(1):62-9. PubMed ID: 9166610
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Incidence of ulcer in an unselected population of 2,000 males].
    Joo L; Samaden R; Dompè M
    Reumatismo; 1967; 19(2):102-6. PubMed ID: 5606274
    [No Abstract]   [Full Text] [Related]  

  • 80. Referral patterns to an osteoporosis clinic for dermatology patients undergoing prolonged corticosteroid therapy.
    Mowad C; Cohen SF; Flandry Fussell N; Martin RE; Ellison CA
    J Am Acad Dermatol; 2018 Mar; 78(3):591-592. PubMed ID: 29447676
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.